title: Potential synergy between SNP and CpG-A or IL-1β in regulating transcriptional activity of IL-20 promoter.
abstract: Psoriasis is a multifactorial cutaneous disorder that in many aspects is influenced by both genetic and environmental elements. IL-20, a member of IL-10 family, is found to be involved in the development of psoriasis. In our previous study, a single-nucleotide polymorphism (SNP) of IL-20-1723CG (rs1713239) was found to be associated with psoriasis progression, especially in those induced by upper respiratory tract infection. To further explore the underlying mechanism, we investigated the function of this specific variant and its cooperative effect with bacterial-like DNA or IL-1β on regulating IL-20 expression. We found that in HaCat cells, both IL-1β and CpG-A triggered a stronger IL-20 promoter activity with the risk-associated G allele in comparison with the nonrisk C allele of rs1713239. Furthermore, on stimulation with IL-1β or CpG-A, an increased level of IL-20 expression was also observed in psoriatic lesions of patients carrying the risk-associated G allele. This study demonstrates that rs1713239 and infection may have potential synergetic effect on modulating the transcriptional activity of IL-20.
authors.affiliation: Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
authors.forename: Lanqi
authors.initials: L
authors.lastname: Wang
authors.affiliation: Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
authors.forename: Kejia
authors.initials: K
authors.lastname: Li
authors.affiliation: Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
authors.forename: Qiannan
authors.initials: Q
authors.lastname: Xu
authors.affiliation: Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
authors.forename: Xiaoying
authors.initials: X
authors.lastname: Chen
authors.affiliation: Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
authors.forename: Feng
authors.initials: F
authors.lastname: Xue
authors.affiliation: Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
authors.forename: Ruofei
authors.initials: R
authors.lastname: Shi
authors.affiliation: Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Electronic address: jie-zheng2001@126.com.
authors.forename: Jie
authors.initials: J
authors.lastname: Zheng
mesh_terms: D000276:Adjuvants, Immunologic / Q000235:genetics; D001706:Biopsy; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005838:Genotype; D057809:HEK293 Cells; D006801:Humans; D053583:Interleukin-1beta / Q000235:genetics*; D007378:Interleukins / Q000235:genetics*; D015603:Keratinocytes / Q000166:cytology / Q000502:physiology*; D009838:Oligodeoxyribonucleotides / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011401:Promoter Regions, Genetic / Q000502:physiology; D011565:Psoriasis / Q000235:genetics* / Q000503:physiopathology; D015533:Transcriptional Activation / Q000502:physiology
chemical_list: D000276:Adjuvants, Immunologic; C408982:CPG-oligonucleotide; D053583:Interleukin-1beta; D007378:Interleukins; D009838:Oligodeoxyribonucleotides; C422042:interleukin 20
references.citation: Drugs Today (Barc). 2009 Nov;45 Suppl B:105-12
references.pmid: 20011701
references.citation: Nature. 2007 Oct 4;449(7162):564-9
references.pmid: 17873860
references.citation: Immunity. 2011 Oct 28;35(4):596-610
references.pmid: 21982596
references.citation: Cell. 2001 Jan 12;104(1):9-19
references.pmid: 11163236
references.citation: Br J Dermatol. 2010 Jun;162(6):1198-205
references.pmid: 20128791
references.citation: J Invest Dermatol. 2006 Jul;126(7):1590-9
references.pmid: 16645593
references.citation: J Immunol. 2007 Feb 15;178(4):2229-40
references.pmid: 17277128
references.citation: Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18049-54
references.pmid: 22006331
references.citation: Genes Immun. 2005 Aug;6(5):407-15
references.pmid: 15889129
references.citation: Br J Dermatol. 2003 Sep;149(3):530-4
references.pmid: 14510985
references.citation: J Immunol. 2001 Oct 1;167(7):3545-9
references.pmid: 11564763
references.citation: J Dermatol. 2002 Sep;29(9):547-55
references.pmid: 12392062
references.citation: Dermatology. 2011 Feb;222(1):24-30
references.pmid: 21109726
references.citation: N Engl J Med. 2009 Jul 30;361(5):496-509
references.pmid: 19641206
references.citation: J Invest Dermatol. 2009 Nov;129(11):2653-60
references.pmid: 19609313
references.citation: J Invest Dermatol. 2009 Jun;129(6):1339-50
references.pmid: 19322214
references.citation: Nat Rev Drug Discov. 2006 Jun;5(6):471-84
references.pmid: 16763660
references.citation: J Invest Dermatol. 2007 Jun;127(6):1337-42
references.pmid: 17344934
references.citation: J Immunol. 2009 Apr 15;182(8):5003-12
references.pmid: 19342680
references.citation: J Invest Dermatol. 2000 Mar;114(3):576-80
references.pmid: 10692120
references.citation: J Invest Dermatol. 2007 Jun;127(6):1326-36
references.pmid: 17255956
references.citation: Cell Mol Immunol. 2007 Feb;4(1):31-41
references.pmid: 17349209
references.citation: Genes Immun. 2004 Mar;5(2):117-21
references.pmid: 14712309
references.citation: Exp Dermatol. 2006 Dec;15(12):991-1004
references.pmid: 17083366
references.citation: N Engl J Med. 2005 May 5;352(18):1899-912
references.pmid: 15872205
references.citation: Clin Otolaryngol Allied Sci. 1997 Dec;22(6):532-5
references.pmid: 9466065
references.citation: J Invest Dermatol. 2007 Feb;127(2):331-41
references.pmid: 17068485
references.citation: Eur J Immunol. 2009 Dec;39(12):3570-81
references.pmid: 19830738
references.citation: J Invest Dermatol. 2003 Dec;121(6):1306-11
references.pmid: 14675174